Treatment Registry
TR-0145 ActiveRecorded September 2, 2026

Compounded tirzepatide

Sold by Aurelius Health Group · every compounded tirzepatide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$199

Medication · Microdose GLP-1 Protocol$199

Added from the figures recorded below.

Price

TermPer monthCharged today
Microdose GLP-1 Protocol

Microdose GLP-1 Protocol $89 first month then $199/month Cancel anytime before next billing cycle. No hidden fees.

source

Per month$199Charged today$89
Visit Aurelius Health Group

We earn nothing from this link. Aurelius Health Group has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

PharmacyRedRock Pharmacy, St. George UT; Health Warehouse, Florence KY; Precision Compounding Pharmacy, Bellmore NY; Triad Rx, Daphne AL
PrescriberAsynchronous review
Cancellation“Cancel for any reason. We require notice at least 72 hours before your next billing date.”

Not yet checked: states, membership and consult fee.

Recorded from aureliushealthgroup.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026Site markets specifically 'Microdose GLP-1' using sub-therapeutic tirzepatide doses (its own outcome calculator is explicitly 'Based on observational data at 1mg microdose tirzepatide') rather than standard full-dose GLP-1 therapy — worth flagging since a reader searching for a standard-dose program would be misled. The comparison table's 'Standard Full Dose' column (2.4 mg/wk injectable, $200-$300+/mo) describes a competitor/reference product, not Aurelius's own offering. Treatment is compounded and shipped from a licensed U.S. pharmacy, but vial-vs-pen was never stated.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0145
Readings
1

Related records

Compounded tirzepatide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 307 records of the same molecule.

Cite this entry

Treatment Registry. (2026). Aurelius Health Group compounded tirzepatide (TR-0145). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0145

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.